Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Current HIV Research|February 18, 2010
Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infectionMassimiliano Berretta, Arben Lleshi, Alessandro Cappellani, et al.The Oncologist|August 27, 2011
Hepatocellular carcinoma in HIV-infected patients: check early, treat hardMassimiliano Berretta, Elisa Garlassi, Bruno Cacopardo, et al.Annals of the New York Academy of Sciences|September 7, 2007
Role of the HLA class II: HCV-related disordersValli De Re, Laura Caggiari, Maria Paola Simula, et al.Haematologica|August 27, 2013
Stem cell mobilization in HIV seropositive patients with lymphomaAlessandro Re, Chiara Cattaneo, Cristina Skert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trialsEvert M Noordijk, Patrice Carde, Noëlle Dupouy, et al.Oncotarget|February 18, 2017
Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter surveyMassimiliano Berretta, Chiara Della Pepa, Paolo Tralongo, et al.Blood|September 10, 2013
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patientsStefan K Barta, Xiaonan Xue, Dan Wang, et al.British Journal of Haematology|October 17, 2009
Genome wide DNA-profiling of HIV-related B-cell lymphomasDaniela Capello, Marta Scandurra, Giulia Poretti, et al.International Journal of Radiation Oncology, Biology, Physics|December 13, 2017
Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized TrialJosé Thomas, Christophe Fermé, Evert M Noordijk, et al.The New England Journal of Medicine|June 13, 2003
Involved-field radiotherapy for advanced Hodgkin's lymphomaBerthe M P Aleman, John M M Raemaekers, Umberto Tirelli, et al.Pageof 15